copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
Mallinckrodt - Wikipedia Mallinckrodt Mallinckrodt Pharmaceuticals plc is an Irish-American manufacturer of specialty pharmaceuticals (namely, adrenocorticotropic hormone), generic drugs and imaging agents [2] In 2017, it had 5,500 employees and sales of $3 2 billion, of which $2 9 billion was from the U S healthcare system [3]
Mallinckrodt and Endo to Combine to Create a Global, Scaled . . . About Mallinckrodt Mallinckrodt is a global business consisting of multiple wholly owned subsidiaries that develop, manufacture, market and distribute specialty pharmaceutical products and therapies
Get to Know Our Specialty Pharmaceutical Company | Mallinckrodt . . . Mallinckrodt’s growing portfolio of specialty pharmaceuticals helps treat a wide variety of health conditions Mallinckrodt’s work reflects its strategic vision to be an innovation-driven specialty pharmaceutical company focused on improving outcomes for patients with severe and critical conditions
Drugmakers Mallinckrodt and Endo to merge - CNBC Mallinckrodt and Endo, drugmakers with a shared history of facing U S opioid litigation, have agreed to merge in a deal valued at nearly $7 billion
Our Products | Mallinckrodt Pharmaceuticals Mallinckrodt has a diverse portfolio of branded products available across a broad range of indications and a broad line of speciality generics Visit our website to learn about our product offerings
Mallinckrodt, Endo Announce Planned Leadership Team for Merged Company The forward-looking statements made herein speak only as of the date hereof and Mallinckrodt and Endo do not assume any obligation to update or revise any forward-looking statement, whether as a result of new information, future events and developments or otherwise, except as required by law
Mallinckrodt Pharmaceuticals - LinkedIn Listening for Needs, Delivering Solutions | Mallinckrodt Pharmaceuticals combined with Endo in 2025 to better serve customers and improve outcomes for the patients we support